GHENT UNIVERSITY Karoline FONCK - International Centre for ...

GHENT UNIVERSITY Karoline FONCK - International Centre for ... GHENT UNIVERSITY Karoline FONCK - International Centre for ...

05.04.2013 Views

the family (Temmerman 1995). Programs involving partner notification should weigh the benefits and risks for the women involved. We have shown a marked difference in pregnancy outcome between women whose partners were treated during pregnancy and those who were not. Although the figures are small and the difference does not reach statistical significance, we think that this effect is a real one. We found an HIV seroprevalence of 22% in RPR-positive women and 12% among the partners tested. The HIV discordance rate was 18%, which corresponds to what has been reported in Uganda (Serwadda 1995), Zambia (McKenna 1997) and Rwanda (King 1993). We found that 35% of the partners of HIV-seropositive women were positive compared with 80% in Rwanda (Allen 1992), 15% in Zaire (Ryder 1990) and 5% in the UK (Johnson 1989). These differences might be explained by the fact that all women in our study were RPR positive. They might be at higher risk of acquiring HIV through their high-risk behavior or through the interaction of the STD with the acquisition of HIV infection (Wasserheit 1992). In conclusion, innovative strategies to improve partner notification are needed, but should take into account the potential disastrous consequences of increased violence, divorce or loss of security. Targeted education could reduce this problem making it possible for the full benefits of partner notification to be appreciated. Studies to design strategies that can motivate more partners to go for treatment after delivery are needed. PREVENTION OF SEXUALLY TRANSMITTED INFECTIONS INCLUDING HIV 79

6.3. A Randomized, Placebo-controlled Trial of Monthly Azithromycin Prophylaxis to Prevent Sexually Transmitted Infections and HIV-1 in Kenyan Sex Workers: Study Design and Baseline Findings. Summary Published in the International Journal of STD & AIDS 2000; 11:804-11 by Fonck K, Kaul R, Kimani J, Keli F, MacDonald K, Ronald A, Plummer F, Kirui P, Bwayo J, Ngugi E, Moses S and Temmerman M. Our objectives were to describe the baseline findings of a trial of antibiotic prophylaxis to prevent sexually transmitted infections (STIs) and HIV-1 in a cohort of Nairobi female sex workers (FSWs). A questionnaire was administered and a medical examination was performed. HIV-negative women were randomly assigned to either one gram azithromycin or placebo monthly. Mean age of the 318 women was 32 years, mean duration of sex work 7 years and mean number of clients was 4 per day. High-risk behavior was frequent: 14% practiced anal intercourse, 23% sex during menses, and 3% used intravenous drugs. While 20% reported condom use with all clients, 37% never use condoms. However, STI prevalence was relatively low: HIV-1 27%, bacterial vaginosis 46%, Trichomonas vaginalis 13%, Neisseria gonorrhoeae 8%, Chlamydia trachomatis 7%, syphilis 6% and cervical intraepithelial neoplasia (CIN) 3%. It appears feasible to access a population of high-risk FSWs in Nairobi with prevention programs, including a proposed trial of HIV prevention through STI chemoprophylaxis. Introduction Sexually transmitted infections are among the most common diseases worldwide, with major medical, social and economic consequences. The prevalence of STIs in the general population in Kenya is unknown, but has been shown to exceed 20% in pregnant women in Nairobi. The prevalence of N. gonorrhoeae, C. trachomatis, Treponema pallidum and HIV-1 among pregnant women were 7%, 9%, 6% and 15% respectively (Temmerman 1994). Surveillance data from antenatal clinics in Nairobi in 1996 revealed an HIV-1 prevalence of 16% (Jackson 1999). PREVENTION OF SEXUALLY TRANSMITTED INFECTIONS INCLUDING HIV 80

6.3. A Randomized, Placebo-controlled Trial of Monthly<br />

Azithromycin Prophylaxis to Prevent Sexually Transmitted<br />

Infections and HIV-1 in Kenyan Sex Workers: Study Design and<br />

Baseline Findings.<br />

Summary<br />

Published in the <strong>International</strong> Journal of STD & AIDS 2000;<br />

11:804-11 by Fonck K, Kaul R, Kimani J, Keli F, MacDonald K,<br />

Ronald A, Plummer F, Kirui P, Bwayo J, Ngugi E, Moses S and<br />

Temmerman M.<br />

Our objectives were to describe the baseline findings of a trial of antibiotic prophylaxis to<br />

prevent sexually transmitted infections (STIs) and HIV-1 in a cohort of Nairobi female sex<br />

workers (FSWs). A questionnaire was administered and a medical examination was<br />

per<strong>for</strong>med. HIV-negative women were randomly assigned to either one gram azithromycin<br />

or placebo monthly. Mean age of the 318 women was 32 years, mean duration of sex work<br />

7 years and mean number of clients was 4 per day. High-risk behavior was frequent: 14%<br />

practiced anal intercourse, 23% sex during menses, and 3% used intravenous drugs. While<br />

20% reported condom use with all clients, 37% never use condoms. However, STI<br />

prevalence was relatively low: HIV-1 27%, bacterial vaginosis 46%, Trichomonas vaginalis<br />

13%, Neisseria gonorrhoeae 8%, Chlamydia trachomatis 7%, syphilis 6% and cervical<br />

intraepithelial neoplasia (CIN) 3%. It appears feasible to access a population of high-risk<br />

FSWs in Nairobi with prevention programs, including a proposed trial of HIV prevention<br />

through STI chemoprophylaxis.<br />

Introduction<br />

Sexually transmitted infections are among the most common diseases worldwide, with major<br />

medical, social and economic consequences. The prevalence of STIs in the general<br />

population in Kenya is unknown, but has been shown to exceed 20% in pregnant women in<br />

Nairobi. The prevalence of N. gonorrhoeae, C. trachomatis, Treponema pallidum and HIV-1<br />

among pregnant women were 7%, 9%, 6% and 15% respectively (Temmerman 1994).<br />

Surveillance data from antenatal clinics in Nairobi in 1996 revealed an HIV-1 prevalence of<br />

16% (Jackson 1999).<br />

PREVENTION OF SEXUALLY TRANSMITTED INFECTIONS INCLUDING HIV 80

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!